Company news

hVIVO plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Appointment of Chief Financial Officer

June 15, 2015

EUR 2m contract with leading European biotech

June 10, 2015

Posting of Annual Report & Notice of AGM

May 28, 2015

New services from Innovenn

May 20, 2015

2014 Annual Report and Financial Statements

April 24, 2015

2014 Audited Preliminary Results

April 16, 2015

Change of Name to hVIVO plc

April 13, 2015

Investor teach-in

April 2, 2015

Contracts for EUR4.1m with US Biotech client

March 30, 2015

Placing to raise £2 million

March 13, 2015

Change of Registered Office

March 6, 2015

New Ordinary Shares

March 4, 2015

Grant of Options

January 28, 2015

Innovenn Board Appointment

December 10, 2014

Innovenn commences production at new facilities

November 20, 2014

EUR1.4m contract win with US firm

November 11, 2014

EUR1.2m Contract with Global Pharmaceutical Comp

October 21, 2014

Strategic Investment in InnoVenn

September 30, 2014

Issue of Consideration Shares

September 8, 2014

hVIVO HCM of GS-5806 in RSV for Gilead Sciences

August 21, 2014

Conditional Placing to raise?33.6 million

August 14, 2014

Acquisition of French CRO

August 5, 2014

hVIVO HCM of AL-8176 in RSV for Alios BioPharma

July 28, 2014

Skin science patent grant

June 19, 2014

Start of hVIVO Challenge Study in Asthma

June 4, 2014

Investor Event

June 2, 2014

Director's Dealing

May 27, 2014

Major contract win

May 16, 2014

2013 Annual Report and Accounts

April 17, 2014

Audited 2013 Preliminary Results

April 9, 2014

Result of general meeting

March 31, 2014

Director Declaration

March 21, 2014

New state of the art biomedical facility in UK

March 19, 2014

Update on the Acquisition of Evocutis plc

March 18, 2014

Placing to raise?1 million & Notice of GM

March 14, 2014

Update of Evocutis plc acquisition

March 13, 2014

Acquisition

March 4, 2014

Acquisition of the trading assets of Evocutis PLC

February 26, 2014

Update re: Aquisition of German based CRO

January 13, 2014

Acquisition of Belfast Based CRO

December 9, 2013

Interim Results

September 27, 2013

Contract Win

August 28, 2013

Conditional Placing to raise?25.5 million

June 14, 2013

Innovation division launch & co-development

May 17, 2013

Project wins

April 26, 2013

2012 Annual Report and Accounts

April 19, 2013

Audited 2012 Preliminary Results

April 10, 2013

Senior Management Appointments

April 9, 2013

Board Appointment

March 14, 2013

Venn Life Sciences expands into Russia

February 7, 2013

← Newer news releases · Older news releases →

Calls

The 5 newest of 18 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.